ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
23.408,10
1,20%
S&P 500
5.675,12
0,64%
Dow Jones
41.841,63
0,85%
Euro vs US Dollar
1,09354
0,15%
Bitcoin
82.800,82
-1,50%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Virpax Pharmaceuticals Inc (VRPX) Börsenkurse

Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc (VRPX)

NASDAQ
0,169
0,0025
(1,50%)
Geschlossen 17 März 9:00PM
Verzögert um 15 Minuten
0,124
-0,045
( -26,63% )
Vor Marktöffnung: 11:44AM
Verzögert um 15 Minuten
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,124
Gebot
0,1242
Fragen
0,126
Volumen
210.011
0,00 Tagesbereich 0,00
0,1213 52-Wochen-Bereich 4,825
Marktkapitalisierung
3,294M
Handelsende
0,169
Handelsbeginn
-
Letzte Trade
100
@
0.124
(formt)
Letzter Handelszeitpunkt
11:33:19
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
5.819.746
Ausgegebene Aktien
26.562.581
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,37
Gewinn pro Aktie (EPS)
-0,45
Erlöse
-
Nettogewinn
-12,07M

Über Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray. Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.virpaxpharma.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Virpax Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VRPX. The last closing price for Virpax Pharmaceuticals was US$0,17. Over the last year, Virpax Pharmaceuticals shares have traded in a share price range of US$ 0,1213 to US$ 4,825.

Virpax Pharmaceuticals currently has 26.562.581 shares in issue. The market capitalisation of Virpax Pharmaceuticals is US$4,49 million. Virpax Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.37.

VRPX Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report
Edgar (US Regulatory)
06 Februar 2025
VRPX (1,50%)

Form 8-K - Current report
Edgar (US Regulatory)
04 Februar 2025
VRPX (1,50%)

Form 8-K - Current report
Edgar (US Regulatory)
30 Januar 2025
VRPX (1,50%)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Edgar (US Regulatory)
28 Januar 2025
VRPX (1,50%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0648-34.32203389830.18880.18880.121311486810.17390055CS
4-0.1644-57.00416088770.28840.33320.121369978670.23431456CS
12-0.207-62.53776435050.3310.5150.121358197460.28590258CS
26-0.64-83.76963350790.7641.050.121343036050.38950475CS
52-3.836-96.86868686873.964.8250.121336576630.81336478CS
156-20.176-99.389162561620.3250.121312737401.20560498CS
260-79.876-99.84580359.7990.1213142285639.14193121CS

VRPX - Frequently Asked Questions (FAQ)

What is the current Virpax Pharmaceuticals share price?
The current share price of Virpax Pharmaceuticals is US$ 0,124
How many Virpax Pharmaceuticals shares are in issue?
Virpax Pharmaceuticals has 26.562.581 shares in issue
What is the market cap of Virpax Pharmaceuticals?
The market capitalisation of Virpax Pharmaceuticals is USD 4,49M
What is the 1 year trading range for Virpax Pharmaceuticals share price?
Virpax Pharmaceuticals has traded in the range of US$ 0,1213 to US$ 4,825 during the past year
What is the PE ratio of Virpax Pharmaceuticals?
The price to earnings ratio of Virpax Pharmaceuticals is -0,37
What is the reporting currency for Virpax Pharmaceuticals?
Virpax Pharmaceuticals reports financial results in USD
What is the latest annual profit for Virpax Pharmaceuticals?
The latest annual profit of Virpax Pharmaceuticals is USD -12,07M
What is the registered address of Virpax Pharmaceuticals?
The registered address for Virpax Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Virpax Pharmaceuticals website address?
The website address for Virpax Pharmaceuticals is www.virpaxpharma.com
Which industry sector does Virpax Pharmaceuticals operate in?
Virpax Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AFRIForafric Global PLC
US$ 13,69
(59,93%)
13
KTCCKeyTronic Corporation
US$ 4,26
(59,55%)
221
LGHLWLion Group Holding Ltd
US$ 0,01
(58,73%)
1
LEELee Enterprises Inc
US$ 12,99
(51,22%)
145
RGCRegencell Bioscience Holdings Ltd
US$ 27,74
(49,95%)
184,48k
ATXIAvenue Therapeutics Inc
US$ 0,5249
(-38,40%)
69,96k
HYPRHyperfine Inc
US$ 0,9352
(-26,94%)
504,79k
AGMHAGM Group Holdings Inc
US$ 0,0772
(-26,89%)
3,83M
VRPXVirpax Pharmaceuticals Inc
US$ 0,124
(-26,63%)
210,01k
ANTEAirNet Technology Inc
US$ 1,21
(-24,84%)
369,65k
GNPXGenprex Inc
US$ 0,4771
(19,28%)
15,79M
BONBon Natural Life Ltd
US$ 0,7038
(14,89%)
15,19M
SYRSSyros Pharmaceuticals Inc
US$ 0,1286
(49,88%)
12,13M
PIIIP3 Partners Inc
US$ 0,1603
(-6,42%)
5M
SHViShares Short Treasury Bond ETF
US$ 110,30
(0,01%)
4,65M

VRPX Finanzen

Finanzen

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
VRPX
Virpax Pharmaceuticals
NASDAQ
CAEJX
Canoe Bond Advantage Fun...
NASDAQ
CDDVX
Ci G520i 2036 Q1 Fund Cl...
NASDAQ
CFQOX
Ci Portfolio Series Cons...
NASDAQ
CBROX
Ci Canadian Bond Corpora...
TG
SDF
K and S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten